EverSource Wealth Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
EverSource Wealth Advisors's DGX Position: Q2 2026 in Review
EverSource Wealth Advisors reduced its Quest Diagnostics (DGX) stake by 46% in Q2 2026, selling an estimated $870K and leaving 5,172 shares worth $1.1M. The position accounts for 0.04% of the portfolio, ranked #333.
EverSource Wealth Advisors first reported a position in DGX in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.88M in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- EverSource Wealth Advisors held 5,172 shares of Quest Diagnostics worth $1.1M as of Q2 2026.
- EverSource Wealth Advisors sold 4,431 Quest Diagnostics shares in Q2 2026, an estimated $870K.
- Quest Diagnostics made up 0.04% of EverSource Wealth Advisors's portfolio in Q2 2026, its #333 holding.
- EverSource Wealth Advisors first reported a position in Quest Diagnostics in Q4 2021 and has held it in 19 quarters since.
- EverSource Wealth Advisors's Quest Diagnostics position peaked at $1.88M in Q1 2026.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.